Maria Piedad
Fernandez Perez

Foto de Maria Piedad

Foto de Hospital Universitario Reina Sofia

Hospital Universitario Reina Sofia

Córdoba, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (6)

2024

Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers, Vol. 16, Núm. 14

2023

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide
Prostate, Vol. 83, Núm. 4, pp. 376-384

2022

Corrigendum to “589P Dynamics of peripheral blood immune profiling associated with tumour progression in metastatic castration resistant prostate cancer (mCRPC)”: [Annals of Oncology 32 suppl. 5 (2021) S637-S638] (Annals of Oncology (2021) 32 suppl. 5(S637-S638) (S0923753421033317), (10.1016/j.annonc.2021.08.1102))
Annals of Oncology

2021

Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
Scientific Reports, Vol. 11, Núm. 1
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis
Haematologica, Vol. 106, Núm. 6, pp. 1636-1646

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study
Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9